Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

BrainStorm Expands Clinical Pipeline to Evaluate NurOwn for Alzheimer's Disease

americanpharmaceuticalreviewJuly 03, 2020

Tag: BrainStorm , Alzheimer's Disease , NurOwn

PharmaSources Customer Service